Loading...
Efficacy and Safety of Ertugliflozin in Patients with Overweight and Obesity with Type 2 Diabetes Mellitus
OBJECTIVE: This study aimed to evaluate ertugliflozin in patients with overweight and obesity with type 2 diabetes mellitus. METHODS: Data from three placebo‐controlled, randomized, Phase 3 studies were pooled. Patients with baseline BMI ≥ 25 (1,377/1,544; 89%) were assessed with a stratification by...
Na minha lista:
| Udgivet i: | Obesity (Silver Spring) |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7217180/ https://ncbi.nlm.nih.gov/pubmed/32202075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/oby.22748 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|